EKNL.US Eko International Cp
- Market cap
- USD 6.34K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Jun 2014.
Is EKNL.US undervalued?
Graham numberThe Graham number of Eko International Cp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Eko International Cp fundamental analysis
No fundamental analysis for Eko International Cp yet.
Eko International Cp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Eko International Cp
EKO International Corp., through its joint venture interest in NeuroVasc Clinical Inc., promotes and distributes frequency rhythmic electrical modulation system equipment used in the treatment of peripheral neuropathy in Canada. The company, through its joint venture interest in NeuroVasc Clinical Inc., also sets up and/or manage clinics to treat patients using FREMSTM equipment. EKO International Corp. is based in Burlington, Canada.
Full company profileEko International Cp financial statements
Eko International Cp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 1996 | 1997 | 2000 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 100K | 100K | - | 0.00 | 117K | 1.68M | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | - | -600K | -693K | 0.00 | 8.24K | 1.20M | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -2.70M | -2.80M | -725K | -10.0K | -1.01M | -211K | 0.00 | -251K | -251K | -43.5K |
| EBITDA | -2.60M | -2.70M | -693K | - | - | - | - | - | - | - |
| Net Income | -2.60M | -3.00M | -802K | -10.0K | -1.01M | -367K | -519K | 0.00 | -413K | -43.5K |
| Balance Sheet | ||||||||||
| Total Assets | 400K | 2.90M | 98.5K | 0.00 | 1.02M | 2.27M | 322K | 322K | 159K | 359K |
| Total Liabilities | 2.30M | 600K | 2.81M | 10.0K | 1.53M | 3.03M | 0.00 | - | 251K | 494K |
| Shareholders' Equity | -1.90M | 2.30M | -2.72M | -10.0K | -504K | -758K | 322K | - | -91.4K | -135K |
| Cash & Short-term Investments | - | 2.30M | 1.50K | 0.00 | 0.00 | 0.00 | 0.00 | -16.00 | - | - |
| Total Debt | 1.70M | 300K | 589K | - | - | - | - | - | - | - |
| Cash Flow | ||||||||||
| Operating Cash Flow | -1.20M | -2.70M | -152K | -380K | -380K | -956K | -520K | -452K | -452K | -244K |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 400K | 400K | 548K | 677K | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -1.20M | -2.70M | -152K | - | - | - | - | - | - | - |
| Ratios | ||||||||||
| ROE | - | -130.4% | - | - | - | - | -161.3% | - | - | - |
| ROA | -650.0% | -103.4% | -813.7% | - | -99.2% | -16.2% | -161.3% | 0.0% | -259.2% | -12.1% |
| Net Profit Margin | -2,600.0% | -3,000.0% | - | - | -870.2% | -21.9% | - | - | - | - |
| Debt to Equity | - | 0.13x | - | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Eko International Cp dividends
Eko International Cp has not paid dividends in the last 10 fiscal years.
Last stock split: 1:300 on Jun 25, 2009.
Who owns Eko International Cp
Ownership data of Eko International Cp is not available yet.
Eko International Cp company profile
- Company name
- Eko International Cp
- Ticker
- EKNL.US
- Exchange
- USA Stocks
- Sector
- Industrials
- Industry
- Industrial Conglomerates
- Fiscal year end
- June
- Address
- 855 Brant Street, Burlington, ON, Canada, L7R 2J6
- Phone
- 289-288-0447
- Website
- -
About Eko International Cp
EKO International Corp., through its joint venture interest in NeuroVasc Clinical Inc., promotes and distributes frequency rhythmic electrical modulation system equipment used in the treatment of peripheral neuropathy in Canada. The company, through its joint venture interest in NeuroVasc Clinical Inc., also sets up and/or manage clinics to treat patients using FREMSTM equipment. EKO International Corp. is based in Burlington, Canada.